Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 248-983-7 | CAS number: 28348-53-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- other: published data
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
Data source
Reference
- Reference Type:
- publication
- Title:
- Metabolism of Sodium Tosylate-35S by Rats and Dogs
- Author:
- Dreyfuss, J., Shekosky, J.M., Ross, J.J. Jr.
- Year:
- 1 971
- Bibliographic source:
- Toxicology and Applied Pharmacology, vol. 20, p. 548-551
Materials and methods
- Objective of study:
- distribution
- excretion
- toxicokinetics
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Purebred beagles were fasted overnight before they were treated. Animals were housed in metabolism cages designed to allow the separate collection of urine and feces. Samples of feces were homogenized with 2-3 vol methanol. About 50-100 mg of homogenate was transferred to a tared scintillation vial containing 1 ml of NCS solubilizer.
The sample was shaken for at least 1hr, bleached with 30% hydrogen peroxide, and counted with 15 ml of Bray scintillation fluid. Samples of urine were counted directly in 15 ml of Bray scintillation fluid.
Blood was analyzed by digesting a 0.2-ml sample in 0.5 ml of 1.0N NaOH and heating overnight at 80 degrees C.
The sample was then bleached with 30% hydrogen peroxide, neutralized with 0.2 ml of 2 -ethylhexanoic acid, and counted with 15 ml of Bray scintillation fluid. For extraction, fecal homogenates were centrifuged; the supernatant fluid was recovered and saved.
A volume of chloroform-methanol (1:1) equal to that of the supernatant fluid recovered above was added to the fecal residue, and the mixture was shaken for 30 min and centrifuged; the supernatant fluid was recovered and saved. This last step was repeated a second time.
The supernatants were combined, and spotted directly for chromatography, or were first concentrated to a suitable volume at 40 -50 degrees C under reduced pressure.
The extraction procedure removed from the feces of rats and dogs that had been treated with sodium p-toluene sulfonate-35S an average of 81.9 and 72.6 % of the radioactivity present, respectively.
In other experiments, when sodium p-toluenesulfonate-35S was added to fecal homogenates from untreated rats and dogs, the procedure extracted 87.0 and 80.0% of the radioactivity, respectively. Radioactivity was measured with a Packard Tri-Carb liquid scintillation spectrometer, Model 3380.
Counting efficiency was determined with automatic external standardization and the use of previously prepared quench curves.
Samples of urine or of fecal extracts were spotted on plates of silica gel Q1-F2 and developed in the following solvent systems: benzene-ammonia-dioxane (35:5:60); n-butanol-100% ethanol-ammonia-Water (40:4:1:9); and 95% ethanol-1 N ammonia (95:5). - GLP compliance:
- not specified
Test material
- Reference substance name:
- Sodium toluene-4-sulphonate
- EC Number:
- 211-522-5
- EC Name:
- Sodium toluene-4-sulphonate
- Cas Number:
- 657-84-1
- Molecular formula:
- C7H8O3S.Na
- IUPAC Name:
- sodium 4-methylbenzene-1-sulfonate
- Test material form:
- solid
- Details on test material:
- Test substance:Purity: 94.9% (isomer ratio, p- 76.7%: o- 23.3%), Impurities: inorganic matter 4.7%
Constituent 1
- Specific details on test material used for the study:
- Sodium p-toluenesulfonate-35S (specific activity: 7.0uCi/mg, radiochemical purity: 99%)
- Radiolabelling:
- yes
Test animals
- Species:
- dog
- Strain:
- Beagle
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Duration and frequency of treatment / exposure:
- Single administration
Doses / concentrations
- Dose / conc.:
- 17.4 mg/kg bw/day (nominal)
- No. of animals per sex per dose / concentration:
- 1/sex/dose
- Control animals:
- not specified
Results and discussion
Main ADME results
- Type:
- excretion
- Results:
- Excretion of the unchanged parent substance measured: urine 84.5% of which 80.4% was excreted in the first 24 hours; feces 17.5% of which 12.2% was excreted in the first 24 hours.
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- The substance is rapidly absorbed given that almost 85% of the substance was excreted in the urine within 24 hours of dosing.
- Details on distribution in tissues:
- Not specified
- Details on excretion:
- The substance was excreted primarily in the urine, with 84.5% being excreted over 4 days.
Toxicokinetic parameters
- Key result
- Toxicokinetic parameters:
- half-life 1st: 75 minutes
Metabolite characterisation studies
- Metabolites identified:
- not specified
- Details on metabolites:
- Chromatographic analysis of excreta indicated that only the unaltered tosylate-35S moeity had been excreted. In none of the three solvent systems employed was the presence of any metabolite detected.
Any other information on results incl. tables
The excretion of radioactivity by dogs with sodium p-toluenesulfonate-35S 17.4 mg/kg is shown in Table 1.
Table1. Average excretion of sodium p-toluenesulfonate-35S, its metabolites, or both in the urine and feces of dogs (oral).
==========================================================
Average % of dose +/- SE Time
------------------------------------------------
(days) Urine Feces Total
----------------------------------------------------------
1 80.4+/-14.1 12.2+/-7.3 92.6+/-8.4
2 1.93+/-0.81 1.83+/-1.02 3.77+/-1.83
3 0.35+/-0.16 1.29+/-0.68 1.64+/-0.84
4 0.25+/-0.12 1.41+/-0.97 1.66+/-1.04
5 0.30+/-0.16 0.78+/-0.44 1.08+/-0.58
Pan rinse 1.30+/-0.73 - 1.30+/-0.73
-------- ---------- ---------
84.5 17.5 102.1
===========================================================
No difference in the amounts of radioactivity excreted was noted between dogs that had been treated with oral administration or intraperitoneal injection. In dogs, maximum levels of sodium p-toluenesulfonate-35S equivalents, 34.01 and 51.37 μg/mL, were present in the blood and plasma, respectively, within 30 min after dosing.
The half-life of the decline of drug equivalents in the plasma was 75 min during the interval of 1-6 hr.
Chromatographic analysis of excreta indicated that only the unaltered p-toluenesulfonate-35S moiety had been excreted.
This study demonstrated that dogs do not metabolize sodium p-toluenesulfonate
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results : no bioaccumulation potential based on study results
The substance is rapidly absorbed following oral gavage adminstration and the substance is excreted unchanged primarily in the urine. - Executive summary:
In a metabolism study the substance was administered to beagle dogs (1 animals/sex/dose) by oral gavage at a dose level of 17.4 mg/kg bw (single administration). Urine and feces were collected daily for 4 days. The substance was excreted unchanged primarily in the urine.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.